|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7076 | (2006.01) |
| A61P 1/16 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 3380104 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16806299.0 |
| Date of filing the European patent application | 2016-11-22 | |
| (97) | Date of publication of the European application | 2018-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-11 |
| (46) | Date of publication of the claims translation | 2021-05-10 |
| (86) | Number | PCT/IL2016/051258 |
| Date | 2016-11-22 |
| (87) | Number | WO 2017/090036 |
| Date | 2017-06-01 |
| (30) | Number | Date | Country code |
| 24272315 | 2015-11-23 | IL |
| (72) |
FISHMAN, Pnina, IL
COHEN, Shira, IL
|
| (73) |
Can-Fite Biopharma Ltd.,
10 Bareket Street Kiryat Matalon, 4951778 Petach Tikva,
IL
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | A3 adenozino receptoriaus ligandas, skirtas ektopiniam riebalų kaupimuisi gydyti |
| AN A3 ADENOSINE RECEPTOR LIGAND FOR USE IN TREATING ECTOPIC FAT ACCUMULATION |
| Payment date | Validity (years) | Amount | |
| 2025-11-03 | 10 | 231.00 EUR |
| 2026-11-22 |